Now showing items 1-5 of 5
Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda
(Journal of the International AIDS Society, 2011-01)
Background: Because men in Africa are less likely to access HIV/AIDS care than women, we aimed to determine if men have differing outcomes from women across a nationally representative sample of adult patients receiving ...
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
(Lippincott Williams & Wilkins, Inc., 2011)
Objective: Evaluations of CD4 cell count and other prognostic factors on the survival of HIV patients in sub-Saharan Africa are extremely limited. Funders have been reticent to recommend earlier initiation of treatment. ...
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy
(Wolters Kluwer Health, Lippincott Williams & Wilkins, 2011-03)
Objective: To examine if there is a significant difference in survival between elderly (>50 years) and nonelderly adult patients receiving combination antiretroviral therapy in Uganda between 2004 and 2010. Design: ...
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis from Uganda
(Annals of Internal Medicine, 2011-08-16)
Background: Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once they initiate cART in Uganda. Design: ...
Predictive value of CD4 cell count nadir on long-term mortality in HIV-positive patients in Uganda
Objective: Although international guidelines recommend initiating antiretroviral therapy (ART) when a patient’s CD4 cell count is <350 cells/μL, most patients in resource-limited settings present with much lower CD4 cell ...